Serum phosphate levels and mortality risk among people with chronic kidney disease. - Wikidata - awgldk - TriplyDB

Serum phosphate levels and mortality risk among people with chronic kidney disease.

Serum phosphate levels and mortality risk among people with chronic kidney disease.

http://www.wikidata.org/entity/Q45198981

about

Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients Vitamin D compounds for people with chronic kidney disease not requiring dialysis Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients Hyperphosphatemia of chronic kidney disease Guidelines for the management of chronic kidney disease Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations The role of phosphorus in the development and progression of vascular calcification Arterial calcification in chronic kidney disease: key roles for calcium and phosphate Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline Phosphorus and the kidney: What is known and what is needed Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients The role of fetuin-A in mineral trafficking and deposition FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease.Vascular calcification: When should we interfere in chronic kidney disease patients and how?Hyperphosphatemia. The hidden killer in chronic kidney disease Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study.Coronary calcification in patients with chronic kidney disease and coronary artery disease.Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.Phosphate and cardiovascular disease The emerging role of phosphate in vascular calcification.Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review.Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients.Vegetarian Diet in Chronic Kidney Disease-A Friend or Foe.Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease.Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?Nutritional Intervention Incorporating Expedited 10 g Protein Counter (EP-10) to Improve the Albumin and Transferrin of Chronic Hemodialysis Patients.The Effect of Diet on the Survival of Patients with Chronic Kidney Disease.Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients.Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease Characterization of mandibular bone in a mouse model of chronic kidney disease.The use of fibroblast growth factor 23 testing in patients with kidney disease.

P2860

Q24187385-07FC561F-6509-4B2A-AF0D-D021AC3C15EF Q24240439-2B783E58-3063-4734-A811-566A0BE659FF Q24244091-52AAEB92-8204-4272-AC6F-D51A1B7C965E Q24645222-1377B292-9429-4EB4-8614-19B15BBD5933 Q24657844-859767BD-7943-43BD-AA26-A9A4256741D2 Q26781361-BE19220F-5D81-442A-983B-5E5F83120CAF Q26823897-1234CEEC-68FC-4140-8B4A-A65F406C8091 Q26827655-B604CF66-6B04-4937-B843-459D0C70B0A9 Q26849298-12ECFE37-EE07-41D8-8A6C-939E161B50DC Q26851216-95B65ECF-055C-4002-BED7-C6FE45EAFCAD Q26863412-F8B9C270-D846-4EB6-A343-061B64B71A12 Q26866391-FAAB7AE5-6523-4DA2-8890-A6C68AE7505E Q26992251-54760B15-E0DA-44BF-A78E-80BD48743A9E Q27006968-7B1CF042-12C3-4CCB-A168-E0DA967A8C71 Q27021447-5F9086D2-F43C-4D93-A505-D9ADCB6BA0B0 Q27687769-0BAB504E-06BC-4793-8E65-9E8C2FBAD21F Q28071582-94A5CAB8-D88A-4E1F-BF91-F388FAD11094 Q28081229-CF38E865-E6E5-41AF-AF39-49C22286ADD7 Q28535055-1D4C45CA-462C-4885-A231-FD42B98440B0 Q30427104-7577FC19-0209-41B8-9C20-AA5AA5696F81 Q30429870-00DFEC3F-2AA3-4047-ABF4-67A6EB4D9668 Q30430904-3B7DE5D0-E225-4CEE-B465-C023185B0D5B Q30433029-08309609-3094-425D-8636-2CF6A74C2D7C Q30473207-C7F4264F-11E9-475C-B993-325706B6EED9 Q33560509-7D5506BA-614C-4598-A0C2-344D180C71BB Q33562017-BD3E63FC-D525-4F66-88EF-8871F81D9A57 Q33566596-DFDFB940-37B5-4A1C-88FF-28CD47CCBB87 Q33595584-4139A5D0-763C-4028-A4BA-0D74C878975C Q33610289-790259FC-577D-4F68-A12E-EB864DAFDBE4 Q33610457-289C505F-A5BE-4434-80E9-55018CF38E8B Q33616816-62EE69BE-0C71-4591-A466-BDA3717ABD7A Q33642939-4CD77943-CE78-410D-9F45-B4249471C4F5 Q33684149-66AF5339-49C2-40D8-9CA7-9D91B84C9197 Q33710275-32178B09-D34C-49A9-AA50-E5B62A3E67D3 Q33749490-CC1D5404-4F19-459E-B5F5-1A113C2A9A5E Q33769983-139B6E5E-AB56-4806-89E4-2A1B75CE90F4 Q33770086-652413B0-FF33-47DC-8D96-A8E33FE72B3A Q33821566-B008A1DB-D66A-4674-A329-7C74ED95A3CE Q33823103-246844A9-3378-4161-A36E-8343FCED45CA Q33835743-FA5FA4A0-0FE1-4B31-9CB1-B5DB663D1648

P2860

Serum phosphate levels and mortality risk among people with chronic kidney disease.

http://www.wikidata.org/entity/Q45198981

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Serum phosphate levels and mortality risk among people with chronic kidney disease.

@en

Serum phosphate levels and mortality risk among people with chronic kidney disease.

@nl

type

label

Serum phosphate levels and mortality risk among people with chronic kidney disease.

@en

Serum phosphate levels and mortality risk among people with chronic kidney disease.

@nl

prefLabel

Serum phosphate levels and mortality risk among people with chronic kidney disease.

@en

Serum phosphate levels and mortality risk among people with chronic kidney disease.

@nl

P1433

Q45198981-2B8AB169-8056-445B-ACB3-5704419B6268

P1476

Q45198981-B6F6C5E1-7BF4-41B2-A512-05C080C0A3D4

P2093

Q45198981-18ABB4F5-8460-450D-9D12-C348CC60FD52

Q45198981-19F156A2-552C-4D0F-8F8C-E072F8FD4C84

Q45198981-322E251A-1199-4385-9650-221FCF143939

Q45198981-83900324-A557-424E-86F1-E7750C65A916

Q45198981-91719FCD-046F-4723-BDEE-2FDF0DC23C51

Q45198981-A831F9BD-48E3-4AA6-B716-EA78E811B841

Q45198981-DB49CF45-9E96-4296-94C7-CDAF8818F8CF

P304

Q45198981-97559BE7-5543-4F06-8E6A-6A00542812AC

P31

Q45198981-C0B95123-06F7-4119-BBE6-1F1A34790197

P356

Q45198981-A9C18443-FFBD-4863-B7A0-8B69223CCE9D

P433

Q45198981-D042BD1F-E3C5-4B51-8081-E51625C3D1B4

P478

Q45198981-668A444B-37C1-44E9-9EB9-5D38FCFD2A5A

P50

Q45198981-E03C9AFC-E1F5-41F5-A375-18DE83A45092

P577

Q45198981-C3609DFD-34B2-4543-AB0F-244E4DA9D5A8

P698

Q45198981-605A570C-283A-4BD3-ADF9-1240DDF26EBC

P356

P1433

Journal of the American Society of Nephrology

P1476

Serum phosphate levels and mortality risk among people with chronic kidney disease.

@en

P2093

Bessie Young

http://www.w3.org/2001/XMLSchema#string

Dennis L Andress

http://www.w3.org/2001/XMLSchema#string

Donald J Patterson

http://www.w3.org/2001/XMLSchema#string

Donald J Sherrard

http://www.w3.org/2001/XMLSchema#string

Joshua N Sampson

http://www.w3.org/2001/XMLSchema#string

Kyle D Rudser

http://www.w3.org/2001/XMLSchema#string

Stephen L Seliger

http://www.w3.org/2001/XMLSchema#string

P304

520-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2004070602

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Bryan R Kestenbaum

P577

2004-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15615819

http://www.w3.org/2001/XMLSchema#string